Charles River Laboratories International, Inc. CRL
NYSE · United States · Commercial Services
$295.01-0.95 (-0.32%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | 3.02 | 2.74 | +10.1% | $1.00B | +2.8% | +13.4%$234.12→$265.51 |
| Q1 2026 | 2026-05-07 | 2.06 | 1.96 | +5.1% | — | — | -2.3%$181.73→$177.62 |
| Q4 2025 | 2026-02-18 | 2.39 | 2.35 | +1.7% | — | — | +3.6%$158.53→$164.24 |
| Q3 2025 | 2025-11-05 | 2.43 | 2.32 | +4.7% | — | — | -3.9%$177.85→$170.88 |
| Q4 2024 | 2025-02-19 | 2.66 | 2.53 | +5.1% | — | — | — |
| Q4 2023 | 2024-02-14 | 2.46 | 2.40 | +2.5% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.